Glukoza 20 Braun

Glukoza 20 Braun is an intravenous solution containing glucose monohydrate as the active ingredient. It is supplied in a sterile liquid form for parenteral administration. The product is manufactured in the European Union and is available by prescription (Rx). Glukoza 20 Braun provides a source of readily absorbable carbohydrate for clinical use. It is commonly used in hospital settings to maintain blood glucose levels during surgery, fasting, or metabolic disorders.

Glukoza 20 Braun is used in clinical practice to provide a rapid source of glucose when oral intake is not possible or when blood glucose needs to be supported.

- Maintenance of blood glucose levels during surgical procedures or anesthesia. - Treatment of acute hypoglycemia when oral glucose is unsuitable. - Component of parenteral nutrition regimens for patients unable to eat. - Support during prolonged fasting or critical illness. - Assisting in certain diagnostic tests that require controlled glucose infusion. - Stabilizing glucose levels in patients with metabolic disorders.

Side effects associated with intravenous glucose solutions can vary in frequency and severity.

Common: - Mild hyperglycemia (elevated blood glucose). - Local irritation at the infusion site. - Nausea or mild gastrointestinal discomfort. - Transient electrolyte shifts, such as low potassium. - Headache or dizziness related to rapid glucose changes.

Serious: - Severe hyperglycemia leading to osmotic diuresis. - Hyperosmolar hyperglycemic state in susceptible individuals. - Allergic reaction or anaphylaxis to formulation components. - Fluid overload or pulmonary edema in patients with cardiac compromise. - Severe electrolyte disturbances, such as hyponatremia.

When administering Glukoza 20 Braun, clinicians should consider several safety measures.

- Verify patient’s blood glucose level before infusion to avoid excessive hyperglycemia. - Adjust infusion rate in patients with renal or cardiac insufficiency to prevent fluid overload. - Monitor electrolytes, especially potassium and sodium, during prolonged therapy. - Use aseptic technique to reduce risk of infection at the IV site. - Exercise caution in patients with known hypersensitivity to glucose solutions or excipients. - Document infusion details and patient response in the medical record.

Glucose infusions can interact with other medications or clinical conditions.

Avoid: - Concurrent administration of high-dose insulin without appropriate glucose monitoring. - Use with drugs that may cause severe hypoglycemia, such as sulfonylureas, without adjusting doses. - Co‑infusion with hypertonic solutions that could exacerbate hyperosmolar states.

Use with caution: - Beta‑blockers, which may mask symptoms of hypoglycemia. - Corticosteroids, which can increase blood glucose levels. - Diuretics that affect electrolyte balance. - Medications that influence renal function, requiring closer monitoring of fluid status.